Eldepryl

   
Google
 
Web NewDrugInformation.com

Eldepryl


Drug - Eldepryl
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Selegiline Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 5MG
The potency of the active ingredient(s), Selegiline Hydrochloride. May repeat for multiple part products.

Applicant - SOMERSET
The firm name holding legal responsibility for Eldepryl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020647
The FDA assigned number to Eldepryl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Eldepryl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 15, 1996
The date Eldepryl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Eldepryl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Eldepryl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Somerset Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Eldepryl.

Eldepryl